VIAD PHARMA ApS: Financial statements 2024
CVR: 36433892
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,843,899 and a net result of DKK 808,813 compared with DKK 376,249 the year before. That is an increase of 46.6% compared with the year before. Equity in the 2024 report amounted to DKK 877,180. The solvency ratio was 43.5%.
- Gross Profit
- DKK 1,843,899
- Profit/Loss
- DKK 808,813
- Equity
- DKK 877,180
- Total Assets
- DKK 2,016,204
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.8 mio. | 809 t. | 877 t. | - |
| 2023 | - | 1.3 mio. | 376 t. | 445 t. | - |
| 2022 | - | 1 mio. | 188 t. | 257 t. | - |
| 2021 | - | 1 mio. | 250 t. | 319 t. | - |
| 2020 | - | 1.3 mio. | 458 t. | 526 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
VIAD PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 1,257,513, and the net result was DKK 376,249.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity in the 2025 report amounted to DKK 236,399.